Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Marijn Verhoef to share Foundation’s work on AMR at Global AMR R&D Hub meeting

The Foundation’s Director of Operations & Research, Marijn Verhoef, will be attending the AMR R&D Hub’s Annual Stakeholder Group Meeting, where he will join a panel discussion. He will focus on sharing insights from the Foundation’s work on AMR (antimicrobial resistance).

Date

19 October 2023

DATE

19 October 2023

LOCATION

Berlin, Germany

FORMAT

In-person

As a member of the Global AMR R&D Hub, the Access to Medicine Foundation has been invited to the annual Stakeholder Group meeting on 19 October 2023. The Foundation’s Director of Operations & Research, Marijn Verhoef, will attend the Meeting in Berlin, during which he will also participate in a roundtable discussion.  

Marijn will highlight the Foundation’s work on AMR, and he will also discuss The Stewardship and Access Plan (SAP) Development Guide, which is a crucial resource in the fight against this rising global health threat. The Foundation provided inputs for the development of SAP, a tool which helps equip pharmaceutical companies and product developers with practical steps to expedite access to new antibacterial products while maintaining responsible usage practices. 

About the AMR R&D Hub 

The Global AMR R&D Hub is a partnership of countries, non-governmental donor organisations and intergovernmental organisations to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach. 

Key features for this meeting will include the Hub’s workplan for 2024-2025 and its Working Groups, with focus areas, studies and collaborations discussed to ensure maximum impact and efficient use of resources.

Cross-sector Programmes

Learn more about our work on antimicrobial resistance
Featured News

What steps are companies taking to help curb AMR by manufacturing responsibly?

22 August 2023
News

Drug makers must address access to antibiotics to help slow the superbug threat

09 June 2022

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved